Trending Topic

roflilumast foam
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The FDA recently approved roflumilast 0.3% foam for the treatment of plaque psoriasis of the scalp and body in both adolescents and adults. To better understand how this newly approved therapy fits into clinical practice, what the data show and which patients are likely to benefit, we spoke with Dr Jennifer Soung (Harbor University of California, Los Angeles and Southern California Dermatology, Santa Ana, CA, USA), a key investigator on the phase 3 ARRECTOR trial.

Acne

An Introduction to Acne

Mark CompleteCompleted
BookmarkBookmarked

We are delighted to introduce touchDERMATOLOGY Future Leader Dr Neelam Vashi, a highly accomplished dermatologist widely recognized for her expertise in cosmetic dermatology, skin of colour and laser medicine. In this Q&A, Dr Vashi shares the values and experiences that shaped her journey in dermatology, her perspective on patient-centred innovation and her vision for a more authentic understanding of beauty.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Close Popup